Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Nanorobot with Hidden Weapon Precisely Targets and Kills Cancer Cells

By HospiMedica International staff writers
Posted on 03 Jul 2024

Researchers have developed nanorobots capable of eliminating cancer cells in mice, utilizing a weapon concealed within a nanostructure that only activates within the tumor environment, thus protecting healthy cells. More...

The research group at Karolinska Institutet (Solna, Sweden) previously developed structures that arrange what are known as death receptors on cell surfaces, leading to cell death. These structures feature six peptides aligned in a hexagonal formation, forming a deadly nanopattern. If deployed as a medication, this configuration would nonspecifically destroy cells throughout the body, which is undesirable. To circumvent this issue, the team encapsulated the lethal mechanism within a nanostructure made of DNA. This method, known as DNA origami, involves using DNA to craft nanoscale structures and has been the team’s research focus for several years. In the new study published in the journal Nature Nanotechnology, the researchers utilized this approach to develop a 'kill switch' that activates under specific conditions.

The researchers have cleverly concealed the lethal weapon so that it reveals itself only within the environment found in and around a solid tumor, effectively creating a nanorobot designed to selectively attack and destroy cancer cells. This activation is triggered by the acidic environment typically present around cancer cells, characterized by a low pH level. Laboratory tests in test tubes showed that at a normal pH of 7.4, the peptide weapon remains hidden within the nanostructure, but it becomes highly destructive when the pH level drops to 6.5. Following this, the team injected these nanorobots into mice with breast cancer tumors, which led to a significant 70% decrease in tumor growth compared to mice treated with a non-active version of the nanorobot.

“We now need to investigate whether this works in more advanced cancer models that more closely resemble the real human disease,” said the study's first author Yang Wang, a researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet. “We also need to find out what side effects the method has before it can be tested on humans.”

Related Links:
Karolinska Institute


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.